Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manting Liu

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
International Journal of Biological Sciences|March 14, 2024
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian CancerJunping Li, Hong Hu, Hui Lian, et al.
International Journal of Biological Sciences|October 21, 2021
Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancerBihui Cao, Manting Liu, Jingjun Huang, et al.
Nature Communications|October 19, 2022
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancerBihui Cao, Manting Liu, Lu Wang, et al.
Journal of Leukocyte Biology|January 28, 2022
CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivoManting Liu, Wensou Huang, Yongjian Guo, et al.
Frontiers in Immunology|December 29, 2025
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategyHongye Tan, Noor Ul Huda Shah, Bingjia He, et al.
Journal of Hematology & Oncology|July 30, 2021
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelinNengzhi Pang, Jingxuan Shi, Le Qin, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
International Journal of Biological Sciences|March 14, 2024
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian CancerJunping Li, Hong Hu, Hui Lian, et al.
International Journal of Biological Sciences|October 21, 2021
Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancerBihui Cao, Manting Liu, Jingjun Huang, et al.
Nature Communications|October 19, 2022
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancerBihui Cao, Manting Liu, Lu Wang, et al.
Journal of Leukocyte Biology|January 28, 2022
CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivoManting Liu, Wensou Huang, Yongjian Guo, et al.
Frontiers in Immunology|December 29, 2025
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategyHongye Tan, Noor Ul Huda Shah, Bingjia He, et al.
Journal of Hematology & Oncology|July 30, 2021
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelinNengzhi Pang, Jingxuan Shi, Le Qin, et al.
Pageof 5